EURIPID survey – Sharing information about confidential agreements

5th May 2021/in News /by Janos Muzsi

In the light of the WHA resolution in 2019 on improving transparency in the medicines’ market, the EURIPID Executive Committee launched a survey to explore feasible options to foster information exchange and cross-country collaboration in this field.

The survey focused on high-cost and on-patent medicines, for which the sharing of price information is potentially more relevant.

The result were presented by the Italian Medicines Agency AIFA in September 2020.

The EURIPID collaboration is currently funded by an annual contribution fee of the participants and – for defined tasks and deliverables – a grant of the EU.

This website is part of the project ’826652 Euripid’ which is co-funded by the European Union’s Health Programme (2014-2020).

The content of this website represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.